Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a)

Journal of Clinical Lipidology

Volumn 9, Issue 4, 2015, Pages 533-541

  Krychtiuk, Konstantin A ^a,b   Kastl, Stefan P ^a   Hofbauer, Sebastian L ^a   Wonnerth, Anna ^a   Goliasch, Georg ^a   Ozsvar Kozma, Maria ^a   Katsaros, Katharina M ^a   Maurer, Gerald ^a   Huber, Kurt ^b,c   Dostal, Elisabeth ^d   Binder, Christoph J ^a   Pfaffenberger, Stefan ^a   Oravec, Stanislav ^d,e   Wojta, Johann ^a,b   Speidl, Walter S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Ludwig Boltzmann Cluster for Cardiovascular Research   (Austria)

^c WILHELMINEN HOSPITAL   (Austria)

^d Krankenanstalten Dr Dostal   (Austria)

^e Comenius University ^*  (Slovakia)

Author keywords

Atherosclerosis; Coronary artery disease; Lipoprotein(a); Monocyte subsets; Oxidized phospholipids

Indexed keywords

APOLIPOPROTEIN B100; ATORVASTATIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; CD14 ANTIGEN; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; PHOSPHOLIPID;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MONOCYTE SUBSET DISTRIBUTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; AGED; ATHEROSCLEROSIS; BLOOD; CELL LINEAGE; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; PATHOLOGY; RISK FACTOR;

AGED; ANTIGENS, CD14; APOLIPOPROTEIN B-100; ATHEROSCLEROSIS; CELL LINEAGE; CORONARY ARTERY DISEASE; FEMALE; GPI-LINKED PROTEINS; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MONOCYTES; OXIDATION-REDUCTION; PHOSPHOLIPIDS; RECEPTORS, IGG; RISK FACTORS;

EID: 84938208805     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2015.04.005     Document Type: Article

References (47)

1. M. Nichols, N. Townsend, P. Scarborough, and M. Rayner Cardiovascular disease in Europe: epidemiological update Eur Heart J 34 39 2013 3028 3034
2. B.G. Nordestgaard, M.J. Chapman, K. Ray, and et al. Lipoprotein(a) as a cardiovascular risk factor: current status Eur Heart J 31 23 2010 2844 2853
3. K.M. Kostner, W. Marz, and G.M. Kostner When should we measure lipoprotein (a)? Eur Heart J 34 42 2013 3268 3276
4. Emerging Risk Factors C S. Erqou, S. Kaptoge, P.L. Perry, and et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality JAMA 302 4 2009 412 423
5. R. Clarke, J.F. Peden, J.C. Hopewell, and et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease N Engl J Med 361 26 2009 2518 2528
6. P.R. Kamstrup Lipoprotein(a) and ischemic heart disease-a causal association? A review Atherosclerosis 211 1 2010 15 23
7. P. Libby, A.H. Lichtman, and G.K. Hansson Immune effector mechanisms implicated in atherosclerosis: from mice to humans Immunity 38 6 2013 1092 1104
8. K.A. Krychtiuk, S.P. Kastl, W.S. Speidl, and J. Wojta Inflammation and coagulation in atherosclerosis Hamostaseologie 33 4 2013 269 282
9. B. Passlick, D. Flieger, and H.W. Ziegler-Heitbrock Identification and characterization of a novel monocyte subpopulation in human peripheral blood Blood 74 7 1989 2527 2534
10. K.U. Belge, F. Dayyani, A. Horelt, and et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF J Immunol 168 7 2002 3536 3542
11. L. Ziegler-Heitbrock The CD14+ CD16+ blood monocytes: their role in infection and inflammation J Leukoc Biol 81 3 2007 584 592
12. A. Schlitt, G.H. Heine, S. Blankenberg, and et al. CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels Thromb Haemost 92 2 2004 419 424
13. L. Ziegler-Heitbrock, P. Ancuta, S. Crowe, and et al. Nomenclature of monocytes and dendritic cells in blood Blood 116 16 2010 e74 e80
14. T. Imanishi, H. Ikejima, H. Tsujioka, and et al. Association of monocyte subset counts with coronary fibrous cap thickness in patients with unstable angina pectoris Atherosclerosis 212 2 2010 628 635
15. M. Kashiwagi, T. Imanishi, H. Tsujioka, and et al. Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris Atherosclerosis 212 1 2010 171 176
16. C. Poitou, E. Dalmas, M. Renovato, and et al. CD14dimCD16+ and CD14+CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis Arterioscler Thromb Vasc Biol 31 10 2011 2322 2330
17. G. Rothe, H. Gabriel, E. Kovacs, and et al. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia Arterioscler Thromb Vasc Biol 16 12 1996 1437 1447
18. G. Rothe, A.S. Herr, J. Stohr, C. Abletshauser, G. Weidinger, and G. Schmitz A more mature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease Atherosclerosis 144 1 1999 251 261
19. K.S. Rogacev, B. Cremers, A.M. Zawada, and et al. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography J Am Coll Cardiol 60 16 2012 1512 1520
20. J.A. Berliner, N. Leitinger, and S. Tsimikas The role of oxidized phospholipids in atherosclerosis J Lipid Res 50 Suppl 2009 S207 S212
21. K.A. Krychtiuk, S.P. Kastl, S. Pfaffenberger, and et al. Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease Atherosclerosis 237 2 2014 589 596
22. R. Kattermann, D. Jaworek, G. Moller, and et al. Multicentre study of a new enzymatic method of cholesterol determination J Clin Chem Clin Biochem 22 3 1984 245 251
23. M.J. Lin, C. Hoke, and B. Ettinger Evaluation of homogeneous high-density lipoprotein cholesterol assay on a BM/Hitachi 747-200 analyzer Clin Chem 44 5 1998 1050 1052
24. N. Rifai, G.R. Warnick, J.R. McNamara, J.D. Belcher, G.F. Grinstead, and I.D. Frantz Jr. Measurement of low-density-lipoprotein cholesterol in serum: a status report Clin Chem 38 1 1992 150 160
25. S. Tsimikas, E.S. Brilakis, E.R. Miller, and et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease N Engl J Med 353 1 2005 46 57
26. S. Tsimikas, S. Kiechl, J. Willeit, and et al. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study J Am Coll Cardiol 47 11 2006 2219 2228
27. S.B. Dowton, and H.R. Colten Acute phase reactants in inflammation and infection Semin Hematol 25 2 1988 84 90
28. P. Ancuta, R. Rao, A. Moses, and et al. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes J Exp Med 197 12 2003 1701 1707
29. A.M. Zawada, K.S. Rogacev, B. Rotter, and et al. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset Blood 118 12 2011 e50 e61
30. J. Cros, N. Cagnard, K. Woollard, and et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors Immunity 33 3 2010 375 386
31. A.L. Catapano, Z. Reiner, G. De Backer, and et al. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Atherosclerosis 217 1 2011 3 46
32. L.B. Nielsen Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux Atherosclerosis 143 2 1999 229 243
33. U. Lundstam, E. Hurt-Camejo, G. Olsson, P. Sartipy, G. Camejo, and O. Wiklund Proteoglycans contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrix Arterioscler Thromb Vasc Biol 19 5 1999 1162 1167
34. S.N. Sotiriou, V.V. Orlova, N. Al-Fakhri, and et al. Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin FASEB J 20 3 2006 559 561
35. D. Rouy, P. Grailhe, F. Nigon, J. Chapman, and E. Angles-Cano Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu Arterioscler Thromb 11 3 1991 629 638
36. L.A. Miles, G.M. Fless, E.G. Levin, A.M. Scanu, and E.F. Plow A potential basis for the thrombotic risks associated with lipoprotein(a) Nature 339 6222 1989 301 303
37. L.A. Miles, and E.F. Plow Lp(a): an interloper into the fibrinolytic system? Thromb Haemost 63 3 1990 331 335
38. P.R. Kamstrup, A. Tybjaerg-Hansen, R. Steffensen, and B.G. Nordestgaard Genetically elevated lipoprotein(a) and increased risk of myocardial infarction JAMA 301 22 2009 2331 2339
39. P.M. Coen, M.G. Flynn, M.M. Markofski, B.D. Pence, and R.E. Hannemann Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population Metabolism 59 12 2010 1775 1783
40. A.S. Jaipersad, E. Shantsila, A. Blann, and G.Y. Lip The effect of statin therapy withdrawal on monocyte subsets Eur J Clin Invest 43 12 2013 1307 1313
41. A. Kadl, A.K. Meher, P.R. Sharma, and et al. Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2 Circ Res 107 6 2010 737 746
42. A. Mantovani, C. Garlanda, and M. Locati Macrophage diversity and polarization in atherosclerosis: a question of balance Arterioscler Thromb Vasc Biol 29 10 2009 1419 1423
43. D.A. Chistiakov, Y.V. Bobryshev, N.G. Nikiforov, N.V. Elizova, I.A. Sobenin, and A.N. Orekhov Macrophage phenotypic plasticity in atherosclerosis: the associated features and the peculiarities of the expression of inflammatory genes Int J Cardiol 184C 2015 436 445
44. D. Dursunoglu, H. Evrengul, B. Polat, and et al. Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation Rheumatol Int 25 4 2005 241 245
45. L. Slunga, O. Johnson, G.H. Dahlen, and S. Eriksson Lipoprotein(a) and acute-phase proteins in acute myocardial infarction Scand J Clin Lab Invest 52 2 1992 95 101
46. A. Langsted, P.R. Kamstrup, and B.G. Nordestgaard Lipoprotein(a): fasting and nonfasting levels, inflammation, and cardiovascular risk Atherosclerosis 234 1 2014 95 101
47. E. Shantsila, L.D. Tapp, B.J. Wrigley, and et al. Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis Atherosclerosis 234 1 2014 4 10